TOKYO -- Nippon Shinyaku probably earned record operating profit and sales in the year ended March, boosted by revenues from new drugs.
The Kyoto-based pharmaceutical company appears to have generated around 15.5 billion yen ($142 million) in group operating profit in fiscal 2016. That is a jump of around 80% from a year earlier. The company's standing projection calls for 13.5 billion yen.